Gilead Says Remdesivir to Cost $2,340 for Five-Day Treatment

Published June 29, 2020

Gilead Sciences Inc. said it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir, or about $2,340 for a typical five-day course of treatment.

Related Stories